Increased radiosensitivity of HPV-positive head and neck cancer cell lines due to cell cycle dysregulation and induction of apoptosis
- PMID: 24715240
- DOI: 10.1007/s00066-014-0605-5
Increased radiosensitivity of HPV-positive head and neck cancer cell lines due to cell cycle dysregulation and induction of apoptosis
Abstract
Background and purpose: Human Papillomavirus (HPV)-related head and neck squamous cell carcinoma (HNSCC) respond favourably to radiotherapy as compared to HPV-unrelated HNSCC. We investigated DNA damage response in HPV-positive and HPV-negative HNSCC cell lines aiming to identify mechanisms, which illustrate reasons for the increased sensitivity of HPV-positive cancers of the oropharynx.
Methods: Radiation response including clonogenic survival, apoptosis, DNA double-strand break (DSB) repair, and cell cycle redistribution in four HPV-positive (UM-SCC-47, UM-SCC-104, 93-VU-147T, UPCI:SCC152) and four HPV-negative (UD-SCC-1, UM-SCC-6, UM-SCC-11b, UT-SCC-33) cell lines was evaluated.
Results: HPV-positive cells were more radiosensitive (mean SF2: 0.198 range: 0.22-0.18) than HPV-negative cells (mean SF2: 0.34, range: 0.45-0.27; p = 0.010). Irradiated HPV-positive cell lines progressed faster through S-phase showing a more distinct accumulation in G2/M. The abnormal cell cycle checkpoint activation was accompanied by a more pronounced increase of cell death after x-irradiation and a higher number of residual and unreleased DSBs.
Conclusions: The enhanced responsiveness of HPV-related HNSCC to radiotherapy might be caused by a higher cellular radiosensitivity due to cell cycle dysregulation and impaired DNA DSB repair.
Similar articles
-
Increased sensitivity of HPV-positive head and neck cancer cell lines to x-irradiation ± Cisplatin due to decreased expression of E6 and E7 oncoproteins and enhanced apoptosis.Am J Cancer Res. 2015 Feb 15;5(3):1017-31. eCollection 2015. Am J Cancer Res. 2015. PMID: 26045983 Free PMC article.
-
HPV-positive HNSCC cell lines but not primary human fibroblasts are radiosensitized by the inhibition of Chk1.Radiother Oncol. 2013 Sep;108(3):495-9. doi: 10.1016/j.radonc.2013.06.035. Epub 2013 Aug 7. Radiother Oncol. 2013. PMID: 23932155
-
Oncolytic activity of reovirus in HPV positive and negative head and neck squamous cell carcinoma.J Otolaryngol Head Neck Surg. 2015 Feb 24;44(1):8. doi: 10.1186/s40463-015-0062-x. J Otolaryngol Head Neck Surg. 2015. PMID: 25890191 Free PMC article.
-
The radiobiology of HPV-positive and HPV-negative head and neck squamous cell carcinoma.Expert Rev Mol Med. 2020 Jul 2;22:e3. doi: 10.1017/erm.2020.4. Expert Rev Mol Med. 2020. PMID: 32611474 Free PMC article. Review.
-
Increased radiosensitivity of HPV-positive head and neck cancers: Molecular basis and therapeutic perspectives.Cancer Treat Rev. 2015 Dec;41(10):844-52. doi: 10.1016/j.ctrv.2015.10.001. Epub 2015 Oct 13. Cancer Treat Rev. 2015. PMID: 26476574 Review.
Cited by
-
[HPV-associated oropharyngeal cancer-incidence, trends, diagnosis, and treatment].Urologe A. 2018 Dec;57(12):1457-1463. doi: 10.1007/s00120-018-0810-4. Urologe A. 2018. PMID: 30421134 Review. German.
-
Increased sensitivity of HPV-positive head and neck cancer cell lines to x-irradiation ± Cisplatin due to decreased expression of E6 and E7 oncoproteins and enhanced apoptosis.Am J Cancer Res. 2015 Feb 15;5(3):1017-31. eCollection 2015. Am J Cancer Res. 2015. PMID: 26045983 Free PMC article.
-
Senescence Induction by Combined Ionizing Radiation and DNA Damage Response Inhibitors in Head and Neck Squamous Cell Carcinoma Cells.Cells. 2020 Sep 1;9(9):2012. doi: 10.3390/cells9092012. Cells. 2020. PMID: 32883016 Free PMC article.
-
Verteporfin suppresses the proliferation, epithelial-mesenchymal transition and stemness of head and neck squamous carcinoma cells via inhibiting YAP1.J Cancer. 2019 Jul 10;10(18):4196-4207. doi: 10.7150/jca.34145. eCollection 2019. J Cancer. 2019. PMID: 31413738 Free PMC article.
-
De-escalation of radiation dose for human papillomavirus-positive oropharyngeal head and neck squamous cell carcinoma: A case report and preclinical and clinical literature review.Oncol Lett. 2016 Jan;11(1):141-149. doi: 10.3892/ol.2015.3836. Epub 2015 Oct 27. Oncol Lett. 2016. PMID: 26870181 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials